SPMDvsXPH
SPDR Portfolio S&P 400 Mid Cap ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| SPMD | XPH | |
|---|---|---|
| Expense ratio | 0.030% | 0.35% |
| Assets | $18.1B | $510M |
| Net flow, 1 month | +$190M | −$39M |
| Net flow, 1 year | +$2.1B | +$256M |
| Return, YTD | +11.0% | +13.6% |
| Return, 1 year | +11.6% | +29.9% |
| Avg daily volume | 1.6M | 183K |
| Holdings | 401 | 41 |
| Listed | Nov 8, 2005 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS